Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United Kingdom (current)IrelandUnited StatesNew ZealandCanadaAustraliaScotlandNorthern Ireland

Company · Manchester

Qiagen Manchester Limited

Research and experimental development on biotechnology

How am I connected?
More
View network map Report an issue

Official record Companies House · updated 27th September 2026 · Sources

Network

The large node is Qiagen Manchester Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 17

  1. Mark Gladwell 2017-2018 Director View profile
  2. Allan Brown 2011-2014 Director View profile
  3. Peer Michael Schatz 2010-2019 Director View profile
  4. Douglas Jon Liu 2010-2017 Director View profile
  5. Thomas Schweins 2009-2020 Director View profile
  6. Godfrey Devlin 2009-2010 Director View profile
  7. Clive James Austin 2009-2009 Director View profile
  8. Jeff James Holder 2008-2009 Director View profile
  9. David Eric Evans 2007-2009 Director View profile
  10. Andrew James Webb 2001-2009 Director View profile
  11. Norman Burden 2001-2005 Director View profile
  12. Dr David Mark Whitecombe 2001-2009 Director View profile
  13. John Edward Riley 2012-2015 Secretary View profile
  14. Kelly Campbell 2011-2012 Secretary View profile
  15. Derek Bannister 2007-2009 Secretary View profile
  16. Stephen Little 2001-2009 Secretary View profile
  17. Shalni Arora 2001-2007 Secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

What it does
Research and experimental development on biotechnology; Other human health activities
Incorporated
14/02/2001
Registered office
Manchester
Previous names
DXS Limited (until 30/07/2010)

Financials

Net assets
£43,588,673
Total assets
£70,831,586
Employees
2.39
Turnover
Not reported (small or micro-entity accounts)
Profit/loss
£11,762,809

Five-year trend

Period endingTurnoverNet assets
2025-12-31Not reported£43,588,673
2025-12-31Not reported£43,588,673
2024-12-31Not reported£31,825,864

Figures from accounts filed at Companies House (iXBRL), period ending 2025-12-31. Where turnover is absent, small and micro-entity accounts are not required to report it, so it is not shown as zero.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

3 directors on the board

10.5y median 8.7y
average tenure
16.8y
longest tenure

Directors past 6 years

First-time vs portfolio directors

First-time (2)

Portfolio (1)

0
also govern a charity
0
left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Manufacturing 2Health and social care 1

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Gaps to watch

  • Several long-serving directors could step down together

Where to look Suggested search: succession planning for long-tenured seats.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
04160032
Status
Active
Type
Private Limited Company
Accounts next due
30/09/2027
Edition
Register edition compiled 27th September 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data